Gilead (GILD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Gilead Sciences (GILD) reported $6.95 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 5.4%. EPS of $2.01 for the same period compares to $1.34 a year ago.The reported revenue represents a surprise of +4.71% over the Zacks Consensus Estimate of $6.64 billion. With the consensus EPS estimate being $1.61, the EPS surprise was +24.84%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Stre ...